Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CPAP effects on atherosclerotic plaques in patients with sleep-disordered breathing and coronary artery disease: The ENTERPRISE trial.
Dohi T, Kasai T, Endo H, Wada H, Yanagisawa N, Nojiri S, Funamizu T, Shitara J, Doi S, Kato Y, Okai I, Iwata H, Isoda K, Okazaki S, Miyauchi K, Daida H. Dohi T, et al. Among authors: funamizu t. J Cardiol. 2019 Jan;73(1):89-93. doi: 10.1016/j.jjcc.2018.07.002. Epub 2018 Aug 31. J Cardiol. 2019. PMID: 30177302 Free article.
Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention.
Endo H, Dohi T, Funamizu T, Shitara J, Wada H, Doi S, Naito R, Konishi H, Ogita M, Iwata H, Kasai T, Okazaki S, Isoda K, Shimada K, Miyauchi K, Daida H. Endo H, et al. Among authors: funamizu t. Circ J. 2019 Feb 25;83(3):630-636. doi: 10.1253/circj.CJ-18-0962. Epub 2018 Dec 12. Circ J. 2019. PMID: 30541988 Free article.
Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T, Iwata H, Nishida Y, Miyosawa K, Doi S, Chikata Y, Shitara J, Endo H, Wada H, Naito R, Ogita M, Dohi T, Kasai T, Okazaki S, Isoda K, Miyauchi K, Daida H. Funamizu T, et al. Cardiovasc Diabetol. 2020 Feb 18;19(1):21. doi: 10.1186/s12933-020-00996-8. Cardiovasc Diabetol. 2020. PMID: 32070335 Free PMC article.
Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
Takahashi N, Dohi T, Funamizu T, Endo H, Wada H, Doi S, Kato Y, Ogita M, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Shimada K. Takahashi N, et al. Among authors: funamizu t. J Cardiol. 2020 Jul;76(1):25-29. doi: 10.1016/j.jjcc.2020.01.013. Epub 2020 Feb 20. J Cardiol. 2020. PMID: 32089480 Free article.
Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention.
Takahashi N, Dohi T, Endo H, Funamizu T, Wada H, Doi S, Kato Y, Ogita M, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Shimada K. Takahashi N, et al. Among authors: funamizu t. J Clin Med. 2020 Apr 6;9(4):1033. doi: 10.3390/jcm9041033. J Clin Med. 2020. PMID: 32268533 Free PMC article.
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis.
Chikata Y, Iwata H, Miyosawa K, Koike T, Yasuda H, Funamizu T, Doi S, Endo H, Wada H, Naito R, Ogita M, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T. Chikata Y, et al. Among authors: funamizu t. Sci Rep. 2022 Mar 24;12(1):5129. doi: 10.1038/s41598-022-09059-2. Sci Rep. 2022. PMID: 35332212 Free PMC article.
21 results